-+ 0.00%
-+ 0.00%
-+ 0.00%

FATE THERAPEUTICS - RECEIVES $15 MLN AWARD FOR PHASE 2 FT819 TRIAL IN LUPUS NEPHRITIS

Reuters·09/25/2026 11:01:33

Please log in to view news